SCHEMBL17312264

SCHEMBL17312264

O=C(O)c1ccc(C(=O)O)c(-c2c3ccc4cc(O)ccc4c3oc3c2ccc2cc(=O)ccc23)c1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SOS1 Q07889 2/20 0.76
DNASE1L3 Q13609 1/20 0.41
PRMT1 Q99873 1/20 0.41
USP2 O75604 3/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
MEN1 O00255 2/20 0.39
POLB P06746 2/20 0.39
KMT2A Q03164 2/20 0.39
ALPL P05186 1/20 0.39
ALPI P09923 1/20 0.39
ALPG P10696 1/20 0.39
MIF P14174 1/20 0.38
MAOA P21397 1/20 0.38
PTPN1 P18031 1/20 0.37
ESR1 P03372 2/20 0.37
ESR2 Q92731 2/20 0.37
CYP2C9 P11712 1/20 0.36
HCAR2 Q8TDS4 1/20 0.36
AKR1B1 P15121 1/20 0.35
CSNK2A2 P19784 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29543257 1.00 SOS1 (0.76) SOS1DNASE1L3PRMT1USP2L3MBTL1
SCHEMBL29544864 0.91 SOS1 (0.76) SOS1DNASE1L3PRMT1USP2L3MBTL1
SCHEMBL13180156 0.91 SOS1 (0.76) SOS1DNASE1L3PRMT1USP2L3MBTL1
SCHEMBL15277723 0.88 SOS1 (0.67) SOS1USP2L3MBTL1MEN1POLB
SCHEMBL10059473 0.86 SOS1 (1.00) SOS1DNASE1L3PRMT1USP2L3MBTL1
SCHEMBL17254331 0.81 SOS1 (0.62) SOS1DNASE1L3PRMT1USP2L3MBTL1
SCHEMBL13015010 0.81 SOS1 (0.74) SOS1DNASE1L3PRMT1USP2L3MBTL1
SCHEMBL2737206 0.81 SOS1 (0.85) SOS1DNASE1L3PRMT1USP2L3MBTL1
SCHEMBL19335118 0.79 SOS1 (0.61) SOS1DNASE1L3PRMT1USP2L3MBTL1
SCHEMBL13180155 0.77 SOS1 (0.61) SOS1DNASE1L3PRMT1USP2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9549988-B2 Pharmaceutical compounds targeted by MIF affinity-tethered moieties RJS Biologics (US) 2017-01-24 US disclosed
US-20150352217-A1 Pharmaceutical Compounds Targeted by MIF Affinity-Tethered Moieties RJS BIOLOGICS LLC 2015-12-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150352217-A1 Pharmaceutical Compounds Targeted by MIF Affinity-Tethered Moieties MIF, HMGB2, HMGB1 SOS1 3636/4885DNASE1L3 420/4885PRMT1 3822/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.